  |
|
Ever since the widespread acknowledgment that publication of research
in the biomedical literature was a prerequisite for credibility,
authors have been forced to sign over the rights to their manuscript
as a requirement of its consideration for publication.
While this may have rankled any number of authors, it was not really
an issue until the last decade or so, when the advent of the Internet
made alternative routes of scientific exchange not only possible,
but also much faster than the traditional media of scientific exchange.
|
Perhaps the most extreme example of these accelerated communications
to date could be found in the latter stages of the human genome
project, where discoveries were initially communicated via real-time
postings on discussion servers.
So what now? Academic authors are no longer satisfied with a few
hundred offprints, they expect to be able to post their new findings
on their own Web page. And, while commercial authors or sponsors
are still mostly forced to purchase reprints for wider circulation,
those with more creative plans for disseminating the results of
their research are increasingly finding themselves frustrated by
the archaic pricing and distribution models available from traditional
publishers.
|
|
In December of 1993, the National
Writers Union (NWU) filed suit against the and others, alleging copyright infringement for
reuse of articles in online database repositories. The NWU represents
the interests of US freelancers, primarily contributing to lay media.
The case made it all the way to the US
Supreme Court, which in June of 2001 reached a decision in favor
of the NWU.
|
While clearly reflecting a growing discontent among the broad sphere
of authors, the Tassini decision has, in practice had little or
no impact on biomedical publishers - other than perhaps to sharpen
up their copyright transfer language.
|
|
The Scholarly
Publishing and Academic Resources Coalition (SPARC) was officially
formed in June 1998 in response to what members saw as the hijacking
of the process of scholarly communications by the commercial publishers.
They favored what they believed was a more balanced system back
when most journals were published by academic presses or the major
professional associations. The primary driver of their concerns
stems from the ever-mounting price increases for peer-reviewed journals
that, when set against the reality of shrinking library budgets,
results in an ongoing reduction in library holdings.
One of SPARC's three strategic initiatives is to encourage the
establishment of cost-effective alternatives to the expensive, top-tier
specialty journals. As confirmation of their success, members point
to examples like The Journal of Vegetation Science, which
was launched in 1990 and has now out-placed the high-priced alternative
Plant Ecology in the Impact
Factor rankings for its specialty.
|
SPARC is becoming increasingly militant. They have posted on their
Website a trio of "how to" guides to encourage authors
to establish alternative journals.
While revolt stirs passions, real change unfortunately always requires
cold, hard cash. The good news for supporters of SPARC is that money
appears to be becoming increasingly available. A recent example
of this was the announcement by the Open
Society Institute that they will fund a pilot project to support
open access to research and scholarly content in any academic discipline.
|
|
Then in 1999 PubMed
Central (PMC) was launched by the National Center for Biotechnology
Information (NCBI) at the U.S. National Library of Medicine (NLM)
to function as the NLM's full-text archive of full text, peer-reviewed
life science literature.
The original plans for PMC made provision for a form of biomedical
preprint server to enable the posting of both peer-reviewed and
non-peer-reviewed information. It also required that any participating
journal provide all of its peer-reviewed content as a full-text
online file immediately upon publication of the parent journal.
The preprint concept seems to have vanished (preprints are frequently
seen in other scientific disciplines, such as physics, where authors
can post the full text of their submitted articles prior to peer
review or publication - they are rare in biomedicine).
In March 2001, PMC even relaxed the requirement to provide complete
full text, and will permit the journal exclusivity on their own
Website for their embargo period of 6-12 months. In this case a
user may search the content, but can only view the full text if
they have access to the journal's password-controlled site.
|
While this represents a significant
departure from the original vision, it does not significantly detract
from the concept of a searchable "single" full text archive.
Interestingly some of the loudest voices raised against this initiative
were from the academic and society publishers, who have come to
rely on the revenue streams from their publications - somewhat in
contrast to the aspirations of the SPARC initiative.
This move by NCBI/NLM has been emulated by the European
Molecular Biology Organization (EMBO) with their E-Biosci
initiative. It should be noted, however, that to date neither initiative
has attracted anything like a critical mass of content.
The concept has also attracted at least one major for-profit initiative,
BioMed Central,
which seems to be emulating the SPARC manifesto by providing a framework
for authors to establish their own, online-only open access journals.
BioMed Central funds its activities by levying a $500 author submission
charge.
It should be noted that this type of publishing initiative, especially
away from the glare of commercial viability, risks what publishers
call "twigging," a situation where increasingly focused
subspecialty journals are published that have an increasingly limited
potential audience. Perhaps this is less of an issue on the online-only,
open access brave new world.
|
|
In late 2000, a small but increasingly potent and vocal grass roots
movement - the Public
Library of Science (PLOS) was formed. Their demands - that all
publishers, commercial or otherwise, make the full text of their
content available either immediately at the latest within 6 months
of original publication in the journal via "an online public
library that would provide the full contents of the published record
of research and scholarly discourse in medicine and the life sciences
in a freely accessible, fully searchable, interlinked form."
|
Signatories to
their open letter, and there were more than 30,000 of them on July
1, 2002, have agreed not to be a reviewer for, an editor of, or to
submit a manuscript to any journal that does not meet their demands
for freely available full text within 6 months. Clearly, given some
of the initiatives discussed above, they are enjoying a growing number
of credible alternatives to submit to. |
|
It is really anyone's guess where this will end. On the one hand,
there is no doubt that there is an increasing desire by researchers
in biomedicine and other scientific disciplines to make the fruits
of their labors freely available to all in a freely-accessible Internet
archive that they believe will accelerate the pace of scientific
discovery.
On the other hand, these same researchers still need the credibility
and tenure support that can, at least right now, still primarily
be gained from publication in one of the "overpriced,"
commercially-published journals. If nothing else, publication in
these journals comes clearly endorsed with their established reputation
for authoritative peer review processes and careful editorial selection.
|
Some of the largest commercial publishers respond with claims that
their online aggregated content initiatives are in concert with
those of the "dissenters," but in practice these initiatives
are never free.
One of the largest, Science
Direct by Elsevier Science, has recently expanded through both
cross-searching with PubMed and a pay-per-view access model. While
this certainly expands access to content, it still falls far short
of the "free after 6 months" requirements of many of the
alternatives.
|
|
|
|
Clearly the debate will continue to rage before a meaningful solution
is reached. We will do our best to keep you informed, and to help
you understand what it means to your publication endeavors.
In the meantime, the choice of vehicles for publication remains
just that - your choice. You can favor PLOS or SPARC, or not, and
select your journals accordingly.
|
Of course in the end someone always has to pay. The reality remains
that even if the copyright issues were resolved, the undertaking
to create a true open-access Web archive of peer-reviewed biomedical
journal articles would require a sophisticated navigation system,
and also very significant storage and bandwidth. Who would pay?
An international consortium of national libraries might present
one possible option.
|
|